Ftse Mib
38.815,82
0,77%
DAX
23.350,39
1,00%
S&P 500
5.842,63
1,12%
NASDAQ
18.552,73
1,46%
Bitcoin
91.537,35
1,00%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ COMPASS Pathways PLC (CMPS) COMPASS Pathways PLC (CMPS) Notizie

COMPASS Pathways PLC

CMPS
4,04
0,00 (0,00%)
06 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/3/202522:36EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
04/3/202523:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202512:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202512:42EDGAR2Form S-3 - Registration statement under Securities Act of..
27/2/202512:30BWCompass Pathways Announces Fourth Quarter and Full-Year 2024..
27/2/202512:29EDGAR2Form 8-K - Current report
27/2/202512:28EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
25/2/202522:00BWCompass Pathways to Participate in TD Cowen 45th Annual..
18/2/202512:30BWCompass Pathways to announce fourth quarter and year-end..
06/2/202500:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202512:30BWCompass Pathways to Participate in Oppenheimer 35th Annual..
21/1/202512:30BWCompass Pathways Appoints Steve Levine, M.D., as Chief..
10/1/202522:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/1/202513:06EDGAR2Form 8-K - Current report
10/1/202513:01BWCompass Pathways Announces Pricing of Underwritten Offering
18/12/202412:30BWCompass Pathways to Be Added to the NASDAQ Biotechnology..
25/11/202422:00BWCompass Pathways to Participate in December Investor..
14/11/202422:35EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
31/10/202411:30EDGAR2Form 8-K - Current report
31/10/202411:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202411:30BWCompass Pathways Announces Third Quarter 2024 Financial..
25/10/202414:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202414:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202412:30BWCompass Pathways to Announce Third Quarter Financial Results..
18/10/202415:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/10/202414:20EDGAR2Form S-3 - Registration statement under Securities Act of..
28/9/202401:56EDGAR2Form SC 13D/A - General Statement of Acquisition of..
24/9/202410:43BWCompass Pathways nimmt am Cowen Psychedelics and Novel..
24/9/202410:42BWCompass Pathways participera au Cowen Psychedelics and Novel..
23/9/202413:00BWCompass Pathways to Participate in Cowen Psychedelics and..
05/8/202414:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202412:31EDGAR2Form 8-K - Current report
01/8/202412:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202412:30GLOBECompass Pathways announces second quarter 2024 financial..
26/6/202412:30GLOBECompass Pathways appoints Lori Englebert as Chief Commercial..
22/5/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202412:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202412:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202412:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:28EDGAR2Form 8-K - Current report
08/5/202412:46EDGAR2Form 8-K - Current report
08/5/202412:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202412:45GLOBECompass Pathways Announces First Quarter 2024 Financial..
08/5/202412:34EDGAR2Form 8-K - Current report
08/5/202412:30GLOBECompass Pathways announces durable improvement in symptoms..
07/5/202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/5/202412:30GLOBECompass Pathways establishes research collaboration with..
29/4/202412:30GLOBECompass Pathways and Journey Clinical establish research..
Apertura: Min: Max:
Chiusura: 4,04

La tua Cronologia

NASDAQ
CMPS
COMPASS Pathways
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci